JP2004509858A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004509858A5 JP2004509858A5 JP2002516054A JP2002516054A JP2004509858A5 JP 2004509858 A5 JP2004509858 A5 JP 2004509858A5 JP 2002516054 A JP2002516054 A JP 2002516054A JP 2002516054 A JP2002516054 A JP 2002516054A JP 2004509858 A5 JP2004509858 A5 JP 2004509858A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- prp
- ungulate
- natural
- binding affinity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 101710138751 Major prion protein Proteins 0.000 claims 16
- 101001068592 Bos taurus Major prion protein Proteins 0.000 claims 5
- 241000124008 Mammalia Species 0.000 claims 5
- 239000000427 antigen Substances 0.000 claims 3
- 102000036639 antigens Human genes 0.000 claims 3
- 108091007433 antigens Proteins 0.000 claims 3
- 239000002299 complementary DNA Substances 0.000 claims 3
- 239000002502 liposome Substances 0.000 claims 3
- 238000000034 method Methods 0.000 claims 2
- 238000004091 panning Methods 0.000 claims 2
- 241000283690 Bos taurus Species 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 230000016784 immunoglobulin production Effects 0.000 claims 1
- 238000002823 phage display Methods 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 238000010839 reverse transcription Methods 0.000 claims 1
- 230000002194 synthesizing effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/627,218 US6537548B1 (en) | 2000-07-27 | 2000-07-27 | Antibodies specific for ungulate PrP |
| PCT/US2001/022648 WO2002010335A2 (en) | 2000-07-27 | 2001-07-17 | ANTIBODIES SPECIFIC FOR UNGULATE PrP |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004509858A JP2004509858A (ja) | 2004-04-02 |
| JP2004509858A5 true JP2004509858A5 (enExample) | 2005-08-25 |
Family
ID=24513726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002516054A Pending JP2004509858A (ja) | 2000-07-27 | 2001-07-17 | 有蹄類ＰｒＰに特異的な抗体 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US6537548B1 (enExample) |
| EP (1) | EP1368644A2 (enExample) |
| JP (1) | JP2004509858A (enExample) |
| AU (2) | AU2001275977B2 (enExample) |
| CA (1) | CA2416029A1 (enExample) |
| WO (1) | WO2002010335A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2301959A3 (en) * | 2002-04-09 | 2013-03-13 | The Scripps Research Institute | Motif-grafted hybrid polypeptides and uses thereof |
| US20060035242A1 (en) | 2004-08-13 | 2006-02-16 | Michelitsch Melissa D | Prion-specific peptide reagents |
| GB0402123D0 (en) * | 2004-01-30 | 2004-03-03 | Protherics Plc | Method |
| US20050256425A1 (en) | 2004-05-11 | 2005-11-17 | Inpro Biotechnology, Inc. | Device, system and method for extracting and preparing brain tissue |
| NZ587255A (en) * | 2005-01-13 | 2012-03-30 | Novartis Vaccines & Diagnostic | Elisa assays using prion-specific peptide reagents |
| WO2006076683A2 (en) * | 2005-01-13 | 2006-07-20 | Novartis Vaccines And Diagnostics Inc. | Isolation and detection of pathogenic prions |
| WO2006102099A2 (en) * | 2005-03-18 | 2006-09-28 | The Regents Of The University Of California | ANTIBODIES SPECIFIC FOR HUMAN AND BOVINE PrP |
| NZ566020A (en) | 2005-09-09 | 2012-08-31 | Novartis Ag | Prion-specific peptoid reagents |
| WO2009134942A1 (en) * | 2008-04-30 | 2009-11-05 | Novartis Ag. | Assay for pathogenic conformers |
| WO2014025785A2 (en) * | 2012-08-06 | 2014-02-13 | Trustees Of Boston University | Prion protein ligands as therapeutic agents for neurodegenerative disorders |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE581863A (enExample) * | 1959-08-06 | |||
| US4806627A (en) | 1987-05-29 | 1989-02-21 | Research Foundation Of Mental Hygiene Inc. | Hybrid cell lines producing monoclonal antibodies dircted against scrapie-associated fibril proteins |
| US5908969A (en) | 1994-05-13 | 1999-06-01 | The Regents Of The University Of California | Method of detecting prions in a sample and transgenic animal used for same |
| US5792901A (en) | 1994-05-13 | 1998-08-11 | The Regents Of The University Of California | Detecting prions in a sample and prion preparation and transgenic animal used for same |
| DE852011T1 (de) | 1995-09-14 | 2001-10-11 | Scripps Res Inst La Jolla | Für natives prp-sc spezifische antikörper |
| US5891641A (en) | 1997-02-21 | 1999-04-06 | The Regents Of The University Of California | Assay for disease related conformation of a protein |
| EP1057022B1 (en) * | 1998-02-20 | 2003-07-09 | The Regents Of The University Of California | Assay for specific strains of multiple disease related conformations of a protein |
| US6528269B1 (en) | 1998-06-22 | 2003-03-04 | Case Western Reserve University | Immunological agents specific for prion protein (PRP) |
| US6261790B1 (en) | 1999-07-15 | 2001-07-17 | The United States Of America As Represented By The Secretary Of Agriculture | Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies |
| BR0012765A (pt) | 1999-07-27 | 2002-04-02 | Imp College Innovations Ltd | Peptìdeo, métodos de fabricar um anticorpo, de fabricar um agente de ligação capaz de ligar-se a uma forma celular de uma proteìna de prion, de remover uma forma celular de uma proteìna de prion de uma amostra, e de usar um anticorpo e/ou agente de ligação, anticorpo, agente de ligação, uso de um anticorpo ou agente de ligação, kit, e , sequência de peptìdeo de uma forma celular de uma proteìna de prion |
-
2000
- 2000-07-27 US US09/627,218 patent/US6537548B1/en not_active Expired - Fee Related
-
2001
- 2001-07-17 CA CA002416029A patent/CA2416029A1/en not_active Abandoned
- 2001-07-17 JP JP2002516054A patent/JP2004509858A/ja active Pending
- 2001-07-17 AU AU2001275977A patent/AU2001275977B2/en not_active Ceased
- 2001-07-17 AU AU7597701A patent/AU7597701A/xx active Pending
- 2001-07-17 WO PCT/US2001/022648 patent/WO2002010335A2/en not_active Ceased
- 2001-07-17 EP EP01953539A patent/EP1368644A2/en not_active Withdrawn
-
2003
- 2003-01-30 US US10/355,780 patent/US7094553B2/en not_active Expired - Fee Related
-
2006
- 2006-05-22 US US11/419,688 patent/US20060239996A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019531055A (ja) | アルカリ安定性免疫グロブリン結合タンパク質 | |
| JP2003505025A5 (enExample) | ||
| JP2004509858A5 (enExample) | ||
| WO2009051555A3 (en) | Modified mhc class i binding peptides | |
| JP2009540838A5 (enExample) | ||
| Stefanescu et al. | Mass spectrometric approaches for elucidation of antigen—antibody recognition structures in molecular immunology | |
| JP5317336B2 (ja) | 質量分析装置を用いたタンパク質定量のための評価用ペプチド、人工標準タンパク質、及びタンパク質の定量方法 | |
| ATE468127T1 (de) | Ii-key/antigene epitop-hybrid-peptid-vakzine | |
| JP2010523994A5 (enExample) | ||
| EP3911947B1 (en) | Method and system of identifying and quantifying antibody fragmentation | |
| WO2005010023A3 (en) | Method for prediction of an epitope | |
| JP7573287B2 (ja) | アフィニティー精製用免疫グロブリン結合タンパク質 | |
| JP2002544237A5 (enExample) | ||
| Schuster et al. | Short cut of protein purification by integration of cell-disrupture and affinity extraction | |
| WO2003018797A3 (en) | Method and device for integrated protein expression, purification and detection | |
| JP6781854B1 (ja) | モノクローナル抗体の酵母による製造方法およびスクリーニング方法 | |
| Soloviev et al. | Peptidomics, current status | |
| CA2542104A1 (en) | Method for the identification of epitopes related to immunogenicity in biopharmaceuticals | |
| JP2005512016A5 (enExample) | ||
| CA2432995A1 (en) | Immunogenic hla-a2 supermotif-restricted peptides | |
| EP0331514A3 (en) | Assaying the duchenne muscular dystrophy protein deletion or defect | |
| RU2010145185A (ru) | Селективное обогащение модифицированных по n-концу пептидов из сложных образцов | |
| WO2003070768A3 (en) | Cd40 splice variants,method of detection thereof, compositions comprising said variant(s) or nucleic acid encoding the same and use thereof | |
| CN113121669B (zh) | 一种人脂联素的抗原模拟表位及制备方法 | |
| WO2006086288A3 (en) | Methods for reducing the symptoms of autoimmunity and inflammation using binding proteins against antigens exposed on dead or dying cells |